Antivirals
- Interim Guidance on the Use of Antiviral Agents for Treatment of Human Infections with Avian Influenza A (H7N9)
- September 30, 2013Interim Guidance on the Use of Antiviral Medications for Chemoprophylaxis of Close Contacts of Persons with Avian Influenza A (H7N9) Virus Infection
Case Definitions
- June 7, 2013 Interim Guidance on Case Definitions to be Used for Novel Influenza A (H7N9) Case Investigations in the United States
Diagnosis and Laboratory Testing
- June 7, 2013 Interim Guidance for Specimen Collection, Processing, and Testing for Patients Who May Be Infected with Avian Influenza A (H7N9) Virus
- Diagnostics for Detecting H7N9 Using rRT-PCR
- June 7, 2013 CDC Health Alert Network (HAN) Update, Human Infections with Avian Influenza A (H7N9) Viruses
- April 5, 2013 CDC Health Alert Network (HAN) Human Infections with Novel Influenza A (H7N9) Viruses
Infection Control
Laboratorians
- June 6, 2013
CDC and USDA Interim Risk Assessment and Biosafety Level Recommendations for Working With Influenza A(H7N9) Viruses - World Health Organization (WHO) Laboratory biorisk management for laboratories handling human specimens suspected or confirmed to contain avian influenza A(H7N9) virus causing human disease Interim recommendations
[PDF, 74 KB]
H7N9 Vaccine Development
- Summary of status of development and availability of avian influenza A(H7N9) candidate vaccine viruses, WHO
- Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza vaccines against avian influenza A(H7N9) virus [PDF, 604 KB]
Resources
CDC Expert Commentary on Medscape
Title: The New Avian Influenza A (H7N9) Virus: What Clinicians Should KnowPosting Date: Thursday, May 09, 2013
Faculty: Alicia M. Fry, MD, MPH
- Page last reviewed: September 30, 2013
- Page last updated: September 30, 2013
- Content source: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
